Analysts Set Sotera Health (NASDAQ:SHC) PT at $15.80

Shares of Sotera Health (NASDAQ:SHC) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $15.80.

SHC has been the subject of a number of recent research reports. Barclays dropped their target price on Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Piper Sandler lowered their price objective on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a report on Wednesday, April 23rd. Wall Street Zen cut shares of Sotera Health from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, The Goldman Sachs Group raised shares of Sotera Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $14.00 to $17.00 in a report on Monday, May 5th.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in SHC. Vanguard Group Inc. boosted its position in Sotera Health by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock valued at $204,154,000 after buying an additional 173,341 shares during the period. Sculptor Capital LP raised its stake in shares of Sotera Health by 80.8% during the first quarter. Sculptor Capital LP now owns 9,037,511 shares of the company’s stock valued at $105,377,000 after acquiring an additional 4,037,511 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Sotera Health by 5.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company’s stock worth $93,811,000 after purchasing an additional 450,761 shares during the period. TPG GP A LLC bought a new stake in shares of Sotera Health in the first quarter worth about $79,126,000. Finally, Two Seas Capital LP grew its stake in shares of Sotera Health by 14.7% in the first quarter. Two Seas Capital LP now owns 3,321,136 shares of the company’s stock worth $38,724,000 after purchasing an additional 425,000 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

NASDAQ:SHC opened at $12.36 on Friday. The company has a market capitalization of $3.51 billion, a P/E ratio of 49.44 and a beta of 1.87. The business has a fifty day simple moving average of $11.76 and a two-hundred day simple moving average of $12.54. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.02. The company had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.13 earnings per share. On average, analysts expect that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.